Everest Re Group - RE Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Everest Re Group in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RE shares.
View RE analyst ratings or view top-rated stocks.

5 brokerages have issued 12-month target prices for Everest Re Group's shares. Their RE share price forecasts range from $344.00 to $426.00. On average, they anticipate the company's share price to reach $382.00 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price.
View analysts price targets for RE or view top-rated stocks among Wall Street analysts.

Everest Re Group's stock was trading at $331.27 at the beginning of 2023. Since then, RE stock has increased by 8.1% and is now trading at $358.02.
View the best growth stocks for 2023 here.

Everest Re Group saw a increase in short interest in February. As of February 15th, there was short interest totaling 405,100 shares, an increase of 17.0% from the January 31st total of 346,100 shares. Based on an average daily volume of 276,300 shares, the short-interest ratio is currently 1.5 days. Approximately 1.4% of the shares of the stock are sold short.
View Everest Re Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our RE earnings forecast.

Everest Re Group will be holding an earnings conference call on Tuesday, May 2nd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Everest Re Group, Ltd. (NYSE:RE) issued its earnings results on Wednesday, February, 8th. The insurance provider reported $12.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.29 by $2.92. The insurance provider earned $3.19 billion during the quarter, compared to the consensus estimate of $3.24 billion. Everest Re Group had a net margin of 4.96% and a trailing twelve-month return on equity of 12.36%. The business's revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the business posted $9.12 earnings per share.
Read the conference call transcript.

Everest Re Group announced a quarterly dividend on Thursday, February 23rd. Stockholders of record on Thursday, March 16th will be paid a dividend of $1.65 per share on Thursday, March 30th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date is Wednesday, March 15th.
Read our dividend analysis for RE.

ETFs with the largest weight of Everest Re Group (NYSE:RE) stock in their portfolio include Invesco KBW Property & Casualty Insurance ETF (KBWP), Ballast Small/Mid Cap ETF (MGMT), SPDR S&P Insurance ETF (KIE), First Trust Financial AlphaDEX Fund (FXO), ASYMmetric Smart S&P 500 ETF (ASPY), Invesco S&P 500 Equal Weight Financials ETF (RYF), Democratic Large Cap Core ETF (DEMZ) and Davis Select Financial ETF (DFNL).

Everest Re Group (NYSE:RE) pays an annual dividend of $6.60 per share and currently has a dividend yield of 1.84%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 43.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, RE will have a dividend payout ratio of 12.45% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for RE.

1 employees have rated Everest Re Group Chief Executive Officer Juan Andrade on Glassdoor.com. Juan Andrade has an approval rating of 100% among the company's employees. This puts Juan Andrade in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Everest Re Group investors own include Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), UnitedHealth Group (UNH), Exxon Mobil (XOM), Bank of America (BAC), iShares Biotechnology ETF (IBB), Northrop Grumman (NOC), Phillips 66 (PSX) and Adobe (ADBE).

Everest Re Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "RE."

Shares of RE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RE stock can currently be purchased for approximately $358.02.

Everest Re Group (NYSE:RE) has a market capitalization of $14.02 billion and generates $12.06 billion in revenue each year. The insurance provider earns $597 million in net income (profit) each year or $15.11 on an earnings per share basis.

The company employs 2,428 workers across the globe.

Everest Re Group's mailing address is 141 Front Street, HAMILTON D0, HM 19. The official website for the company is www.everestre.com. The insurance provider can be reached via phone at (441) 295-0006, via email at investor.relations@everestre.com, or via fax at 441-295-4828.